Professional Summary
Professional Overview
Paolo Rizzardi is a seasoned biotechnology and healthcare executive with extensive experience in drug development, clinical research, and strategic business leadership. As the Co-Founder, Chairman, and CEO of Altheia Science, he draws on his deep industry expertise to drive the company's mission of developing innovative therapies for unmet medical needs.
Experience Summary
Current Role
As the Co-Founder, Chairman, and CEO of Altheia Science, Paolo is responsible for setting the strategic vision, leading the executive team, and overseeing all aspects of the company's operations. Under his guidance, Altheia Science has become a recognized player in the biotechnology sector, with a focus on developing cutting-edge cell and gene therapies.
In addition to his role at Altheia Science, Paolo also co-founded and serves as the Managing Partner of AurorA-TT, a venture capital firm that invests in early-stage healthcare and life sciences companies.
Career Progression
Prior to co-founding Altheia Science and AurorA-TT, Paolo held the position of General Manager at MolMed, a leading cell and gene therapy company, from 2001 to 2017. During his tenure, he played a pivotal role in the company's growth and the advancement of its clinical pipeline. Earlier in his career, Paolo served as a Dirigente Medico (Medical Director) at the Clinic of Infectious Diseases at the San Raffaele Scientific Institute in Milan, Italy, and as an Assistant and Senior Assistant in Medicine at the Division of Infectious Diseases at the Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland.
Academic Background
Paolo holds a medical degree from the University of Milan, with a specialization in Infectious Diseases. His academic background and clinical experience have provided him with a deep understanding of the healthcare and biotechnology sectors, which he leverages in his leadership roles.
Areas of Expertise
- Biotechnology and pharmaceutical industry expertise
- Cell and gene therapy research and development
- Clinical trial design and execution
- Strategic business planning and execution
- Entrepreneurship and venture capital investments
- Scientific and medical leadership
Professional Impact
Under Paolo's leadership, Altheia Science has emerged as a prominent player in the cell and gene therapy space, with several promising pipeline candidates in various stages of development. He has also been instrumental in the success of AurorA-TT, which has invested in numerous innovative healthcare startups.
Conclusion
With his extensive experience, entrepreneurial spirit, and proven track record of success, Paolo Rizzardi is a respected leader in the biotechnology and healthcare industries. His dedication to advancing innovative therapies and his ability to drive strategic growth continue to position him as a valuable asset to the companies he leads and the broader healthcare ecosystem.
